In the last trading session, 2.04 million shares of the Scilex Holding Company (NASDAQ:SCLX) were traded, and its beta was 1.08. Most recently the company’s share price was $0.42, and it changed around -$0.03 or -5.79% from the last close, which brings the market valuation of the company to $102.92M. SCLX currently trades at a discount to its 52-week high of $2.63, offering almost -526.19% off that amount. The share price’s 52-week low was $0.38, which indicates that the current value has risen by an impressive 9.52% since then. We note from Scilex Holding Company’s average daily trading volume that its 10-day average is 1.34 million shares, with the 3-month average coming to 2.14 million.
Scilex Holding Company stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended SCLX as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Scilex Holding Company is expected to report earnings per share of -0.1 for the current quarter.
Scilex Holding Company (NASDAQ:SCLX) trade information
Instantly SCLX has showed a red trend with a performance of -5.79% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.5250 on recent trading dayincreased the stock’s daily price by 20.0%. The company’s shares are currently down -0.80% year-to-date, but still down -4.56% over the last five days. On the other hand, Scilex Holding Company (NASDAQ:SCLX) is -16.15% down in the 30-day period. We can see from the shorts that 4.91 million shares have been sold at a short interest cover period of 3.25 day(s).
Scilex Holding Company (SCLX) estimates and forecasts
Scilex Holding Company share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -75.76 percent over the past six months and at a 28.23% annual growth rate that is well above the industry average of 16.50%. The year-over-year growth rate is expected to be 21.09%, up from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 14.87M in revenue for the current quarter. 3 analysts expect Scilex Holding Company to make 16.8M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 13.46M and 10.88M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 10.45%. Forecasts for the next quarter put sales growth at 54.36%.
SCLX Dividends
Scilex Holding Company’s next quarterly earnings report is expected to be released in February.
Scilex Holding Company (NASDAQ:SCLX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 24.22% of Scilex Holding Company shares, and 14.47% of them are in the hands of institutional investors. The stock currently has a share float of 19.09%.
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Oct 31, 2024 . The former held 5.94 shares worth $2.51 million, making up 3.10% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 3.71 shares worth around $1.57 million, which represents about 1.94% of the total shares outstanding.
